Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
acute myeloid leukemia
adverum biotechnologies
alder biopharmaceuticals
ambit biosciences
amgen
athena countouriotis
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brett zbar
bristol-myers squibb
calcitonin gene-related peptide
chronic migraine
clinical trials
cormorant asset management
daiichi sankyo
david rind
detroit blog main
detroit top stories
eli lilly
episodic migraine
eptinezumab
erenumab
fda
food and drug administration
fremanezumab
galcanezumab
halozyme therapeutics
hbm healthcare investments
hbm partners
indiana blog main
indiana top stories
What
drug
gets
2
×
new
2
×
amgen
approval
athena
biotech
cancer
candidates
ceo
chief
class
countouriotis
developed
fda
financing
head
medical
medicines
mezzanine
migraine
million
names
nod
officer
old
pain
preventive
promoted
push
raised
round
starts
therapeutics
tp
won
year
Language
Current search:
gets
×
new
×
" san francisco blog main "
×
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines